Topic: Please provide comments: 2007 Gastro-Intestinal Cancers Symposium
Dear friends,
Next week I will travel to Orlando, Florida to attend the Gastro-Intestinal Cancers Symposium. Due to a very generous invitation from the Colorectal Cancer Coalition, I am able to attend the Symposium as the patient advocate representative for the Cholangiocarcinoma Foundation. (Stacie announced the Cholangiocarcinoma Foundation here: http://www.cholangiocarcinoma.org/punbb … hp?id=277) The GI Symposium sessions on Bile Duct Cancer are rolled in with the sessions on pancreatic cancer since these cancers behave similarly.
I will do my best to report the content of these sessions once I return. However, while I am at the Symposium, I think I will be in a good position to speak with many of the top cholangiocarcinoma specialists from around the world. Consequently, I hope that the community on here will review the topics listed below and provide any comments and/or questions you may like addressed.
The sessions I am attending are as follows:
General Session I: Prevention, Screening, and Diagnosis
-Screening for Familial Pancreatic Cancer: Clinical and Genetic Insights
-Evaluation of Bile Duct Strictures: How Do We Know if it is Cancer?
-Advances in the Imaging of Hepatobiliary Cancers
General Session II: Multidisciplinary Treatment
-Conformal Radiation Therapy for Primary Hepatobiliary Cancers
-Locally Advanced versus Metastatic Pancreatic Cancer: Do We Need to Treat These Groups of Patients Differently?
-Chemoembolisation and Ablation for HCC Techniques
-Bile Duct Cancer: How Aggressive Should We Be?
General Session III: Translational Research
-Epigenetic Inactivation of Tumor Supressor Genes in HCC
-Why is Pancreatic Cancer so Difficult to Treat? Stem Cell Resistance in Pancreatic Cancer
-GIST: The Use of Detailed Mutational Analysis to Guide Therapy
General Session IV: Controversies
-Do We Really Help our Patients when We Treat Them for Advanced Stage Pancreatic Cancer?
I am very excited to attend this conference and cannot wait to report back on the information shared by the speakers and attendees.
As an aside, we welcome any questions the community may have regarding the Cholangiocarcinoma Foundation. While it may not be immediately apparent, the members of the Cholangiocarcinoma Foundation are busy at work behind-the-scenes addressing the necessary start-up details. We hope to have the website up soon, and that the members of this community become involved as the Foundation continues to grow.
Best regards,
Sara